These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 25947278

  • 1. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial.
    Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi GJ, Sinnaeve P, Vrolix M, D'hooge J, Adriaenssens T.
    EuroIntervention; 2016 Apr 20; 11(13):1457-67. PubMed ID: 25947278
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
    Dubois C, Adriaenssens T, Ughi G, Wiyono S, Bennett J, Coosemans M, Ferdinande B, Sinnaeve P, D'hooge J, Desmet W.
    Catheter Cardiovasc Interv; 2013 Feb 20; 81(3):E155-64. PubMed ID: 22745031
    [Abstract] [Full Text] [Related]

  • 4. STACCATO (Assessment of Stent sTrut Apposition and Coverage in Coronary ArTeries with Optical coherence tomography in patients with STEMI, NSTEMI and stable/unstable angina undergoing everolimus vs. biolimus A9-eluting stent implantation): a randomised controlled trial.
    Adriaenssens T, Ughi GJ, Dubois C, De Cock D, Onsea K, Bennett J, Wiyono S, Sinnaeve P, Coosemans M, Ferdinande B, Belmans A, D'hooge J, Desmet W.
    EuroIntervention; 2016 Apr 08; 11(14):e1619-26. PubMed ID: 25420791
    [Abstract] [Full Text] [Related]

  • 5. Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes.
    Adriaenssens T, Byrne RA, Dibra A, Iijima R, Mehilli J, Bruskina O, Schömig A, Kastrati A.
    Eur Heart J; 2008 Dec 08; 29(23):2868-76. PubMed ID: 19001472
    [Abstract] [Full Text] [Related]

  • 6. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
    Bennett J, Adriaenssens T, Desmet W, Dubois C.
    Catheter Cardiovasc Interv; 2016 Nov 15; 88(6):843-853. PubMed ID: 27184586
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
    Kervinen K, Niemelä M, Romppanen H, Erglis A, Kumsars I, Maeng M, Holm NR, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galløe A, Narbute I, Sondore D, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Helqvist S, Vikman S, Wiseth R, Aarøe J, Jokelainen J, Thuesen L, Nordic PCI Study Group.
    JACC Cardiovasc Interv; 2013 Nov 15; 6(11):1160-5. PubMed ID: 24262616
    [Abstract] [Full Text] [Related]

  • 8. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C, EXECUTIVE Trial Investigators.
    JACC Cardiovasc Interv; 2013 Oct 15; 6(10):1012-22. PubMed ID: 24055444
    [Abstract] [Full Text] [Related]

  • 9. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
    Hoye A, van Mieghem CA, Ong AT, Aoki J, Rodriguez Granillo GA, Valgimigli M, Tsuchida K, Sianos G, McFadden EP, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW.
    Int J Cardiovasc Intervent; 2005 Oct 15; 7(1):36-40. PubMed ID: 16019613
    [Abstract] [Full Text] [Related]

  • 10. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F, Porto I, Angioli P, Grotti S, Ducci K, Falsini G, Bolognese L.
    Am Heart J; 2013 Nov 15; 166(5):920-6. PubMed ID: 24176449
    [Abstract] [Full Text] [Related]

  • 11. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
    Adriaenssens T, Dens J, Ughi G, Bennett J, Dubois C, Sinnaeve P, Wiyono S, Coosemans M, Belmans A, D'hooge J, Vrolix M, Desmet W.
    EuroIntervention; 2014 Aug 15; 10(4):439-48. PubMed ID: 25138182
    [Abstract] [Full Text] [Related]

  • 12. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study.
    Erglis A, Kumsars I, Niemelä M, Kervinen K, Maeng M, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galløe A, Narbute I, Sondore D, Mäkikallio T, Ylitalo K, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Syvänne M, Helqvist S, Kjell N, Wiseth R, Aarøe J, Puhakka M, Thuesen L, Nordic PCI Study Group.
    Circ Cardiovasc Interv; 2009 Feb 15; 2(1):27-34. PubMed ID: 20031690
    [Abstract] [Full Text] [Related]

  • 13. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
    Serruys PW, Chevalier B, Dudek D, Cequier A, Carrié D, Iniguez A, Dominici M, van der Schaaf RJ, Haude M, Wasungu L, Veldhof S, Peng L, Staehr P, Grundeken MJ, Ishibashi Y, Garcia-Garcia HM, Onuma Y.
    Lancet; 2015 Jan 03; 385(9962):43-54. PubMed ID: 25230593
    [Abstract] [Full Text] [Related]

  • 14. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García Del Blanco B, Seidelberger B, Iñiguez A, Gómez-Recio M, Masotti M, Velázquez MT, Sanchís J, García-Touchard A, Zueco J, Bethencourt A, Melgares R, Cequier A, Dominguez A, Mainar V, López-Mínguez JR, Moreu J, Martí V, Moreno R, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C, RIBS V Study Investigators, under the auspices of the Working Group on Interventional Cardiology of the Spanish Society of Cardiology.
    J Am Coll Cardiol; 2014 Apr 15; 63(14):1378-86. PubMed ID: 24412457
    [Abstract] [Full Text] [Related]

  • 15. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC, Otto S, Gassdorf J, Nitsche K, Janiak F, Scheller B, Goebel B, Jung C, Figulla HR.
    Circ Cardiovasc Interv; 2014 Dec 15; 7(6):760-7. PubMed ID: 25371536
    [Abstract] [Full Text] [Related]

  • 16. Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
    Buysschaert I, Sanidas E, Hasegawa T, Koo BK, Honda Y, Fitzgerald PJ, Verheye S.
    Catheter Cardiovasc Interv; 2014 Dec 01; 84(7):1062-70. PubMed ID: 24478226
    [Abstract] [Full Text] [Related]

  • 17. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T, Dens J, Ughi G, Coosemans M, Onsea K, Dubois C, Sinnaeve P, Vrolix M, Desmet W.
    EuroIntervention; 2011 May 01; 7 Suppl K():K100-5. PubMed ID: 22027717
    [Abstract] [Full Text] [Related]

  • 18. Optical coherence tomography analysis of the stenting of saphenous vein graft (SOS) Xience V Study: use of the everolimus-eluting stent in saphenous vein graft lesions.
    Papayannis AC, Michael TT, Yangirova D, Abdel-Karim AR, Kohlhaas J, Mahmood A, Addo T, Haagen D, Makke L, Roesle M, Rangan B, Banerjee S, Brilakis ES.
    J Invasive Cardiol; 2012 Aug 01; 24(8):390-4. PubMed ID: 22865309
    [Abstract] [Full Text] [Related]

  • 19. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
    Hasegawa T, Ako J, Koo BK, Miyazawa A, Sakurai R, Chang H, Dens J, Verheye S, Grube E, Honda Y, Fitzgerald PJ.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):34-41. PubMed ID: 19089934
    [Abstract] [Full Text] [Related]

  • 20. Approach to coronary bifurcation lesions using the everolimus-eluting stent: comparison between a simple strategy and a complex strategy with T-stenting.
    Ruiz-Salmerón RJ, Valenzuela LF, Pérez I, Fuentes M, Rodríguez-Leiras S, Vizcaíno M, Carrascosa C, Marcos F.
    Rev Esp Cardiol (Engl Ed); 2013 Aug 01; 66(8):636-43. PubMed ID: 24776332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.